Dara-KRd Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of daratumumab, carfilzomib, lenalidomide and dexamethasone that is used for the treatment of plasma cell (multiple) myeloma.

**Synonyms:** - Carfilzomib/Daratumumab/Dexamethasone/Lenalidomide - Carfilzomib/Lenalidomide/Dexamethasone/Daratumumab - Dara-KRd - Dara-KRd - Daratumumab-Carfilzomib-Lenalidomide-Dexamethasone - Daratumumab/Carfilzomib/Lenalidomide/Dexamethasone - Daratumumab/Carfilzomib/Lenalidomide/Dexamethasone Regimen - Darzalex/Kyprolis/Revlimid/Dexamethasone - Darzalex/Kyprolis/Revlimid/Dexamethasone Regimen